Product Conceptualization is complete and the Biosymtec Monitor is ready for the final Design Phase of development which will result in a first prototype, followed by the final Development Phase which will result in a production pilot run of 1,000 devices for Clinical Trials.
The mechanical design and electrical design engineers are in place as are the software engineers. Due to the thoroughness of the Conceptualization Phase, the project is expected to be completed in just 35 weeks from launch. The Biosymtec Medical CTO will oversee every phase of the project.
The company is presently entertaining funding options, strategic partnerships and licensing arrangements to expedite the fulfillment of Biosymtec Medical's mission. For more information, please contact Tom French, President and CEO, through the Contact page.
Thomas W. French
President and CEO